Key Metrics
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Topics Covered
- Cancer
- Lung cancer
- Computed tomography
- Anaplastic lymphoma kinase
- Progression-free survival
- Mutant
- Immunotherapy
- Epidermal growth factor receptor
- Lung
- Immune checkpoint
- Chemoradiotherapy
- Overall survival
- Artificial intelligence
- Ablation
- Lung squamous cell carcinoma
- Toxicity
- Confidence interval
- Mesothelioma
- Lung cancer screening
- Surgical resection
Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in TRANSLATIONAL LUNG CANCER RESEARCH ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure?
- 1 Mar 24
- Translational Lung Cancer Research
-
Full paper
Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients.
- 1 Mar 24
- Translational lung cancer research
-
Full paper
The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic review.
- 1 Mar 24
- Translational lung cancer research
-
Full paper
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells.
- 1 Mar 24
- Translational lung cancer research
-
Full paper
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
- 1 Mar 24
- Translational lung cancer research
-
Full paper
Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer.
- 1 Mar 24
- Translational lung cancer research
Scite analysis
Powered by scite_
1.8k articles received 16.7k citations see all
- 519 Supporting
- 15,896 Mentioning
- 65 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 19 Errata
- 0 Expression of Concern
FAQs
How long has TRANSLATIONAL LUNG CANCER RESEARCH been actively publishing?
TRANSLATIONAL LUNG CANCER RESEARCH has been in operation since 2012 till date.
What is the publishing frequency of TRANSLATIONAL LUNG CANCER RESEARCH ?
TRANSLATIONAL LUNG CANCER RESEARCH published with a Bi-monthly frequency.
How many articles did TRANSLATIONAL LUNG CANCER RESEARCH publish last years ?
In 2023, TRANSLATIONAL LUNG CANCER RESEARCH published 247 articles.
What is the eISSN & pISSN for TRANSLATIONAL LUNG CANCER RESEARCH ?
For TRANSLATIONAL LUNG CANCER RESEARCH,eISSN is 2226-4477 and pISSN is2218-6751.
Who is the publisher of TRANSLATIONAL LUNG CANCER RESEARCH ?
AME PUBLISHING COMPANY is the publisher of TRANSLATIONAL LUNG CANCER RESEARCH.